Olaparib for breast cancer and prostate cancer – two of the most common cancers – in April 2024 A new immunotherapy – Dostarlimab – for
As per studies, in 2024, there will be approximately 4,820,000 new cancer cases in China with around 2,370,000 deaths due to cancer. With such a large prevalence of cancer in the region, the consumption of cancer drugs is likely to increase in the market. Global Metastatic Cancer Drug Market: Competitive Landscape
The researchers used the new tool, described in Nature Communications, to synthesize 32 new drug candidates for cancer. New AI platform designs tomorrow's cancer drugs (2024
Cancer Research Day 2024: New Cancer Drugs and Clinical Milestones sarcoma, targeting specific tumor antigens to treat this rare and
AstraZeneca, AstraZeneca cancer deal, cancer drugs, healthcare news, cancer news, The deal came after Astra struck a deal in November with
They may include new drugs or drug combinations, new approaches to prostate cancer Metastatic prostate cancer treatment. If a patient's prostate cancer
Lung cancer immunotherapy was first approved by the Food and Drug Administration (FDA) in 2024. It has since become an essential new lung cancer treatment for early, recurrent, and advanced lung cancers.
Budget 2024: Cancer patient devastated that government won't fund new drugs.
Citation: New immunotherapy drug effective for melanoma, other cancers (2024, June 3)
Comments
Please tell me 2024 is gonna bring part 10
July 2024: SO MUCH MORE TO COME
November 2024: nothing new has come